Top section
Top section
International investors take most of the book for the first time as Zabłocki's investment firm says it expects to make no further sales
Despite rough market conditions and angst over rates, array of deals have been well taken
It is difficult to see issuance conditions growing much better in the foreseeable future
Data
More articles
More articles
More articles
-
China-based biotechnology firm Mabpharm is looking for the greenlight to list in Hong Kong, having filed a draft IPO prospectus with the city’s stock exchange. -
Tesla has raised the equivalent of $521m from the loan market, helping fund its Shanghai factory.
-
Peking University Founder Group Co priced a $200m bond tap on Friday, getting ahead of a disappointing non-farm payroll report..
-
Citi's head of capital market origination in Asia Pacific is taking over the bank's Indian operation.
-
The operator of Ecuador’s largest airport finally raised the bond market funding it was seeking on Friday, eventually increasing the size of the deal by $50m as some investors were attracted to a rarely seen yield.
-
Central American development bank Cabei will return to US bond markets for the first time since 2012 after a better than expected two notch upgrade from S&P left it keen to enter the realm of true SSAs, said its CFO. But the issuer will be doing so without Fitch, after deciding the rating agency’s methodology did not reflect its new business model.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
